Ivoclar Vivadent AG Product Pipeline Analysis
| Publication Date | August 2008 |
|---|---|
| Publisher | Global Markets Direct |
| Product Type | Report |
| Pages | 26 |
| ISBN Number | not applicable |
| Product Code | GMD04850 |
Summary
This report is an insightful source for data, analysis and strategic insights into a Ivoclar Vivadent AG's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.
Scope
- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.
Reasons to buy
- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.
Content
- 1 List of Tables
- 1.2 List of Figures
- 2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook Dental Devices
- 3 Business Description
- 3.1 Business Overview
- 3.2 Major Products and Services
- 3.2.1 Overview
- 4 History
- 5 Competitors
- 6 Key Employees
- 7 Key Employee Biographies
- 8 Company Statement
- 9 Locations And Subsidiaries
- 9.1 Head Office
- 9.2 Other Locations & Subsidiaries
- 10 Ivoclar Vivadent AG Pipeline Products
- 10.1 Ivoclar Vivadent AG Product Pipeline Analysis
- 10.1.1 Ivoclar Vivadent AG Pipeline Products By Equipment Type
- 10.1.2 Ivoclar Vivadent AG Pipeline Products By Development Stage
- 10.1.3 Ivoclar Vivadent AG Pipeline Products By Therapy Area
- 10.2 IPS e.max Press LT
- 10.2.1 Product Description
- 10.2.2 Product Status
- 10.3 IPS e.max CAD LT
- 10.3.1 Product Description
- 10.3.2 Product Status
- 10.4 IPS e.max ZirCAD
- 10.4.1 Product Description
- 10.4.2 Product Status
- 10.5 IPS e.max Ceram Gingiva Shades
- 10.5.1 Product Description
- 10.5.2 Product Status
- 10.1 Ivoclar Vivadent AG Product Pipeline Analysis
- 11 Appendix
- 11.1 Methodology
- 11.1.1 Coverage
- 11.1.2 Secondary Research
- 11.1.3 Primary Research
- 11.1.4 Expert Panel Validation
- 11.2 Contact Us
- 11.3 About Global Markets Direct
- 11.4 Disclaimer
- 11.1 Methodology
- 1 List of Tables
- Table 1: Ivoclar Vivadent AG,Key Facts
- Table 2: Ivoclar Vivadent AG, Key Employees,
- Table 3: Ivoclar Vivadent AG, Other Locations
- Table 4: Ivoclar Vivadent AG, Subsidiaries
- Table 5: Ivoclar Vivadent AG Pipeline Products by Equipment Type
- Table 6: Ivoclar Vivadent AG Pipeline Products By Development Stage
- Table 7: Ivoclar Vivadent AG Pipeline Products By Therapy Area
- 1.2 List of Figures
- Figure 1: Ivoclar Vivadent AG Pipeline Products By Development Stage
- Figure 2: Global Markets Direct Methodology
About this Product
Delivery Details
Product features / use
| Scope | Expert Insight/Opinion | ![]() |
| Profiles | In-depth Company Insight | ![]() |
| Features | Primary Research Data | ![]() |
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories
















